BRAF-V600E AND P53 MUTATION AS A POTENTIAL PROGNOSTIC MARKERS OF REMISSION DURATION

被引：0

作者：

Kryachok, I. ^{[1
]}

Skrypets, T. ^{[1
]}

Novosad, O. ^{[1
]}

Khranovska, N. ^{[2
]}

Svergun, N. ^{[2
]}

Grabovoy, O. ^{[2
]}

Antoniuk, S. ^{[2
]}

机构：

[1] Natl Canc Inst, Oncohematol, Kiev, Ukraine

[2] Natl Canc Inst, Expt Oncol, Kiev, Ukraine

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PB1945

引用

页码：764 / 765

页数：2

共 50 条

[21] Low-Dose BRAF-Inhibitors in the Treatment of Histiocytic Disorders with the BRAF-V600E Mutation [J].

Ruan, Gordon ;

Goyal, Gaurav ;

Abeykoon, Jithma P. ;

Bennani, N. Nora ;

Rech, Karen ;

Young, Jason ;

Shah, Mithun Vinod ;

Go, Ronald S. .

BLOOD, 2019, 134

[22] Identification of potential inhibitors targeting BRAF-V600E mutant melanoma cells [J].

Kadioglu, Onat ;

Saeed, Mohamed E. M. ;

Greten, Henry J. ;

Mayr, Katharina ;

Schrama, David ;

Roos, Wynand P. ;

Efferth, Thomas .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) :1086-1089

[23] Investigation of Mismatch Repair Protein, BRAF V600E Mutation, and P53 Expression in Thyroid Anaplastic Carcinoma [J].

Lai, Wei-An ;

Hang, Jen-Fan .

MODERN PATHOLOGY, 2019, 32

[24] Investigation of Mismatch Repair Protein, BRAF V600E Mutation, and P53 Expression in Thyroid Anaplastic Carcinoma [J].

Lai, Wei-An ;

Hang, Jen-Fan .

LABORATORY INVESTIGATION, 2019, 99

[25] BRAF-V600E expression correlates with ameloblastoma aggressiveness [J].

Fregnani, Eduardo R. ;

da Cruz Perez, Danyel E. ;

de Almeida, Oslei Paes ;

Fonseca, Felipe Paiva ;

Soares, Fernando A. ;

Castro-Junior, Gilberto ;

Alves, Fabio A. .

HISTOPATHOLOGY, 2017, 70 (03) :473-484

[26] Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab [J].

Shahabi, Vafa ;

Whitney, Gena ;

Hamid, Omid ;

Schmidt, Henrik ;

Chasalow, Scott D. ;

Alaparthy, Suresh ;

Jackson, Jeffrey R. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (05) :733-737

[27] Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis [J].

Minoo, P. ;

Moyer, M. P. ;

Jass, J. R. .

JOURNAL OF PATHOLOGY, 2007, 212 (02) :124-133

[28] Prognostic implications of the BRAF-V600E mutation in papillary thyroid carcinoma based on a new cut-off age stratification [J].

Gan, Xiaoxiong ;

Shen, Fei ;

Deng, Xingyan ;

Feng, Jianhua ;

Lu, Jiabao ;

Cai, Wensong ;

Peng, Lina ;

Zheng, Weipeng ;

Wang, Weijia ;

Huang, Peidan ;

Chen, Zhen ;

Guo, Mengli ;

Xu, Bo .

ONCOLOGY LETTERS, 2020, 19 (01) :631-640

[29] Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients [J].

Shin, Mi Kyung ;

Kim, Jeong Won ;

Min, Soo Kee ;

Lee, Dong Jin ;

Kim, Jin Hwan ;

Lee, Seung Chul ;

Chung, Bong Wha ;

Ju, Young Su .

ONCOLOGY LETTERS, 2015, 10 (03) :1882-1888

[30] Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab [J].

Vafa Shahabi ;

Gena Whitney ;

Omid Hamid ;

Henrik Schmidt ;

Scott D. Chasalow ;

Suresh Alaparthy ;

Jeffrey R. Jackson .

Cancer Immunology, Immunotherapy, 2012, 61 :733-737

← 1 2 3 4 5 →